Authors

Reshma Mahtani, Miami Cancer InstituteFollow

The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results

Publication Date

1-1-2024

Content Type

Article

PubMed ID:

37916267

Additional Authors:

Additional authors and institutional affiliations

Comments

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/

Citation

Rugo, H. S., Im, S. A., Joy, A. A., Shparyk, Y., Walshe, J. M., Sleckman, B., Loi, S., Theall, K. P., Kim, S., Huang, X., Bananis, E., Mahtani, R., Finn, R. S., & Diéras, V. (2024). The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results. Future oncology (London, England), 20(1), 5–16. https://doi.org/10.2217/fon-2023-0407